Clinically Relevant Mesenchymal Stem Cell Populations for Research

Clinically Relevant Mesenchymal Stem Cell Populations for Research

Renovos offer unique Bone Marrow Mesenchymal Stem Cells (MSCs), which have been isolated from patients with Osteoarthritis. Renovos provide heterogeneous populations of MSCs for biologics and biomaterial testing.

By applying clonal culture techniques, Renovos MSCs are supplied at the highest purity and at an early passage, allowing for cell expansion.

Renovos stem cells offer the following key advantages:
• Clinically relevant age range for testing therapeutics/biomaterials designed for the elderly, adults or adolescents
• Donors with clinical presentations -osteoarthritis; as a suitable model for relevant drug/biomaterial testing
• Early passages and guaranteed cell expansion – P2 stocks, >10 population doublings under optimal conditions
• Detailed flow cytometric analysis – for expression of common mesenchymal stem/progenitor cell markers, including for STRO-1, CD73, CD90, CD105
• Multipotency – tested for osteo-, chondro- and adipogenic differentiation in vitro
• Pathogen free – HBV/HCV/HIV, bacteria, mycoplasma and fungi free
• Various levels of purity of the stem cell populations available upon request: unselected mesenchymal, STRO-1 cell-enriched, Clonal
• Inventory available upon request, detailing lot availability, donor age and sex.
• Lot specific Certificate of Analysis are also available to view.
• Next day delivery available.

Currently, the following products are available:
Bone Marrow Mesenchymal Stem Cells – Osteoarthritic, 500,000 Cells
Product Code: REN-OA-500

Bone Marrow Mesenchymal Stem Cells – Osteoarthritic, 1 million Cells
Product Code: REN-OA-1M

Please do contact us if you require MSCs from an alternate disease state, as we may be able to provide a custom product.

 

Clinically Relevant Mesenchymal Stem Cell Populations for Research